|
|
| Dr. Gurbel discusses the variablility in response to Clopidogrel |
Dr. Gurbel discusses the variablility in response to Clopidogrel and the concept of
Clopidogrel resistance. Keywords: P2Y12 inhibition, antiplatelet, plavix.
Sponsorship for interviews this year at TCT 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from Daiichi Sankyo Lilly,
Genentech, Pfizer, Sanofi-Aventis, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|